Holland and Barrett has identified magnesium as its leading supplement for 2025, following the sale of 45 million capsules. This massive spike in demand coincides with research suggesting that a significant portion of the British population is currently deficient in the mineral.
The 45 million capsule surge and the global market's doubling trajectory
The massive sales volume reported by Holland and Barrett is not an isolated event but part of a much larger econoic shift. As the report highlights, the international magnesium market is projected to nearly double in size over the next decade. this growth is being fueled by a wave of social media content where millions of viewers are introduced to the mineral's potential for enhancing msucle strength and cognitive function.
This trend reflects a growing consumer interest in preventive health measures.. While social media platforms act as a catalyst for awareness, the underlying demand is rooted in a global movement toward targeted nutritional intervention, moving away from general multivitamins toward specific mineral supplementation.
The mystery of why 60% of Britons are magnesium deficient
Recent studies indicate that nearly 60% of British adults are not meeting their magnesium requirements, yet many remain unaware of this nutritional gap. Because the human body cannot produce this essential mineral on its own, individuals must rely entirely on dietary intake. While nutrient-dense foods like mackerel, pumpkin seeds, and leafy greens are effective, they are not always staples in the modern British diet.
The report notes that while the NHS recommends daily intakes of 270mg for women and 300mg for men, achieving these levels through food alone can be difficult. For instance, one might need to consume 100g of almonds or cashews to hit these targets. This gap between dietary reality and physiological necessity is what is driving the current market explosion.
How magnesium glycinate is targeting the sleep crisis
Consumers are increasingly moving away from traditional sleeping pills in favor of specific magnesium compounds like magnesium glycinate, also known as magnesium bisglycinate. a 2025 randomized, double-blind trial involving 155 adults with sleep difficulties found that 250mg of elemental bisglycinate significantly improved sleep symptoms over a four-week period.
Dr. Naomi Newman-Beinart explains that this specific form helps regulate the sleep hormone melatonin and supports GABA, a neurotransmitter that promotes calmness. Furthermore,a meta-analysis suggests that magnesium supplementation can reduce the time it takes for older adults to fall asleep by roughly 17 minutes. This scientific backing is a primary driver for the popularity of the glycinate form among health-conscious consumers.
Who is at risk from exceeding the 400mg daily limit?
Despite the popularity of these supplements, there are critical questions regarding the safety of high-dose regimens. The NHS advises that total daily intake should not exceed 400mg to avoid side effects like diarrhea or more serious issues involving heart rhythm and blood pressure. Dr. Hanul Bhandari , a sleep and neurology speecialist, warns that for individuals with already normal magnesium levels, taking extra doses is essentially redundant.
There is also a significant concern for those with underlying health issues. The report states that individuals managing kidney disease, heart block, or the autoimmune condition myasthenia gravis should consult a medical professional before starting any magnesium regimen. without clinical guidance, the rush toward supplementation could pose risks to these vulnerable populations.
Comments 0